Makale
Tam Makale
Uluslararası
2019
Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep-2 to 5-Fluorouracil.
Clinical Cancer Drugs
Cilt 6 · 01.09.2019
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Barlak, N., Sanli, F., Capik, O., Daşdemir, E., AYDIN KARATAŞ, E., TÜRKEZ, H., & KARATAŞ, Ö. F. (2019). Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep-2 to 5-Fluorouracil. Clinical Cancer Drugs, 6. https://doi.org/10.2174/2212697x06666190906165309
BibTeX
@article{barlak2019-78072,
author = {Barlak, Neslişah and Sanli, Fatma and Capik, Ozel and Daşdemir, Elanur and AYDIN KARATAŞ, ELANUR and TÜRKEZ, HASAN and KARATAŞ, ÖMER FARUK},
title = {Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep-2 to 5-Fluorouracil.},
journal = {Clinical Cancer Drugs},
year = {2019},
volume = {6},
issn = {2212-697X},
doi = {10.2174/2212697x06666190906165309},
url = {https://akademik.atauni.edu.tr/yayinlar/78072-metformin-treatment-sensitizes-human-laryngeal-cancer-cell-line-hep-2-to-5}
}